SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT REVENUE

	Three months ended March 31,
	2025			2024
Revenues		1,529			1,511
Cost of Revenues:
Material and Labor		1,025			974
Other cost of revenues		212			245
Total Cost of Revenues		1,237			1,219
Research and development (R&D)
Payroll and Benefits		855			683
Share based compensation		668			468
Clinical trials		1,160			784
Other R&D		1,376			690
Total Research and development		4,059			2,625
Selling and marketing (S&M)
Payroll and Benefits		1,979			822
Share based compensation		217			250
Other S&M		554			165
Total Selling and marketing		2,750			1,237
General and administrative (G&A)
Payroll and Benefits		1,676			915
Share based compensation		1,779			1,784
Other G&A		1,488			1,145
Total General and administrative		4,943			3,844
Financial Income, net;		294			382
Segment net Loss		(11,166	)		(7,032	)